High dose chemotherapy for breast cancer queriedBMJ 1998; 317 doi: https://doi.org/10.1136/bmj.317.7157.490a (Published 22 August 1998) Cite this as: BMJ 1998;317:490
- Deborah Josefson
- San Francisco
No evidence exists to support high dose chemotherapy rather than standard regimens for treating breast cancer, according to a report in the Lancet (1998;352:515-21).
Despite recent advances in detection, breast cancer recurrence is commonSome reports have suggested that high dose chemotherapy might be superior to standard treatments, and several small scale reports have also suggested an increase in disease free survival with high dose regimens compared with conventional treatments. Some centres routinely offer …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial